Myriad Genetics grants second manufacturing and marketing approval for BRACAnalysis Diagnostic System

Myriad Genetic Laboratories, a wholly-owned subsidiary of Myriad Genetics has announced  the Japanese Ministry...

June 21, 2019 | Friday | News
Eisai discovers new anti-cancer compound

Eisai, a leading global research and development-based pharmaceutical company headquartered in Japan has announced ...

June 21, 2019 | Friday | News
Ricoh announces strategic business partnership with Elixirgen Scientific

Ricoh Company has announced it has entered into a strategic business partnership with Elixirgen Scientific, Inc. to deve...

June 20, 2019 | Thursday | News
Japan the first to approve Roche’s personalised medicine Rozlytrek

Roche has announced that Japan’s Ministry of Health, Labour and Welfare (MHLW) has approved Rozlytrek® (entrec...

June 19, 2019 | Wednesday | News
Daiichi Sankyo’s VANFLYTA® receives approval for the treatment of Relapsed/Refractory FLT3-ITD AML

Daiichi Sankyo Company has announced that the Ministry of Health, Labor and Welfare (MHLW) of Japan has approved VANFLYT...

June 18, 2019 | Tuesday | News
Catalys Pacific to advance early-stage life sciences innovation

Catalys Pacific, a new venture capital firm in Japan built by a global team seasoned in life sciences investin...

June 18, 2019 | Tuesday | News
Teijin Pharma starts exclusive sale of TMS device in Japan

Teijin Pharma Limited, the core company of the Teijin Group’s healthcare business, has announced that it has ...

June 17, 2019 | Monday | News
Terumo secures exclusive global rights to Orchestra BioMed's SEB

Japan headquartered Terumo Corporation, a leading global medical device manufacturer has announced that it has secured e...

June 14, 2019 | Friday | News
BiomX licenses novel targets for phage therapy program

BiomX Ltd., a microbiome company developing both natural and engineered phage therapies has announced it has licensed a ...

June 13, 2019 | Thursday | News
Acucela gets EMA approval for Emixustat to treat Stargardt disease

Acucela Inc. (“Acucela”), a clinical-stage ophthalmology company and wholly-owned subsidiary of Kubota Pharm...

June 11, 2019 | Tuesday | News
Sosei Heptares to receive new $3 million milestone payment from Pfizer

Sosei Group Corporation and its strategic alliance partner Pfizer announce that a new clinical candidate from their mult...

June 10, 2019 | Monday | News
Hamamatsu Photonics develops novel 3D fluorescence scanner

Hamamatsu Photonics K.K. has developed a novel 3D fluorescence scanning method called “Zyncscan™” that...

June 11, 2019 | Tuesday | News
Parexel appoints Dr Makoto Sugita to lead its Japan organization

Parexel, a leading provider of Clinical, Consulting and Commercial solutions to accelerate the development of innovative...

June 7, 2019 | Friday | News
FujiFilm Corp introduces novel, fully integrated continuous production system

Japan headquartered FUJIFILM Corporation has announced an initial $10M USD investment to establish a...

June 7, 2019 | Friday | News
Takeda to discontinue trial in AL Amyloidosis

Takeda Pharmaceutical Company Limited has announced that the Phase 3 TOURMALINE-AL1 clinical trial in patients with...

June 6, 2019 | Thursday | News
A unique solution to boost immunization in developing countries

Gavi, the Vaccine Alliance, NEC Corporation, and Simprints Technology Ltd. have signed a memorandum of understanding on ...

June 10, 2019 | Monday | News
Otsuka Chemical acquires Cefixime business of Astellas Pharma

Otsuka Chemical Co., Ltd has announced its acquisition on cefixime business from Astellas Pharma, Inc. on 5 June 2019,...

June 10, 2019 | Monday | News
PeptiDream announces strategic partnership with drug-delivery expert PharmaIN

PeptiDream Inc., a public Kanagawa-based biopharmaceutical company, on 5 June 2019, announced a strategic partnership wi...

June 6, 2019 | Thursday | News